Physician profile
Daniel Garrett
NPI 1891987111
$266.68
in general payments reported to CMS, 2019-2025
11 companies · $24.06 in 2025
The $24.06 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $93.65 · 2024: $21.26 · 2025: $24.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $45.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $45.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $44.53 | 2022 | |
| Janssen Pharmaceuticals, INC | $28.40 | 2021 | |
| Genentech, INC. | $25.00 | 2022 | |
| Genentech USA, INC. | $24.76 | 2021 | |
| Genzyme Corporation | $24.12 | 2022 | |
| Sun Pharmaceutical Industries INC. | $24.06 | 2025 | |
| Biomarin Pharmaceutical INC. | $21.54 | 2021 | |
| Abiomed | $21.26 | 2024 | Impella |
| Hema Biologics, LLC | $20.33 | 2021 | |
| Global Blood Therapeutics, INC. | $19.17 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.